Trimel to Report First Quarter 2014 Results and Host Conference Call to Update Investors
02 Maio 2014 - 4:37PM
Marketwired
Trimel to Report First Quarter 2014 Results and Host Conference
Call to Update Investors
TORONTO, ONTARIO--(Marketwired - May 2, 2014) - Trimel
Pharmaceuticals Corporation (TSX:TRL) will report its first quarter
financial results for the period ended March 31, 2014 on Thursday,
May 8th 2014 after market close.
Management of the Company will host a conference call to discuss
these results and update investors on the status of its business on
Friday, May 9th 2014, at 8:30 a.m. Eastern Daylight Time. Following
the discussion, Trimel executives will address inquiries from
investment analysts.
To access the call live, please dial 416-340-2216 or
1-866-223-7781. Listeners are encouraged to dial in 10 minutes
before the call begins to avoid delays.
A replay of the conference call will be available until 7:00
p.m. Eastern Daylight Time on Friday, May 16th, 2014 by dialing
905-694-9451 or 1-800-408-3053, using access code: 6382379#.
About Trimel
Trimel is a specialty pharmaceutical company actively developing
medications for male hypogonadism, female sexual dysfunction and
various respiratory disorders. An NDA for CompleoTRT™, a product
utilizing Trimel's licensed bioadhesive intranasal gel technology,
has been accepted for review by the FDA for regulatory approval in
the United States. For more information, please visit
www.trimelpharmaceuticals.com.
Trimel Pharmaceuticals CorporationKenneth HowlingChief Financial
Officer(416)
679-0536ir@trimelpharmaceuticals.comwww.trimelpharmaceuticals.com
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Trilogy International Pa... (TSX:TRL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Trilogy International Partners Inc da Toronto Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Trimel Pharmaceuticals Corp